T 1639/16 (Composition with a botulinum neurotoxin / MERZ PHARMA) of 01.02.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T163916.20220201
- Date of decision
- 1 February 2022
- Case number
- T 1639/16
- Online on
- 31 March 2022
- Petition for review of
- -
- Application number
- 10181506.6
- IPC class
- A61K 8/64A61P 21/02A61K 31/728A61P 25/06A61Q 19/08A61K 47/32A61K 47/26A61K 47/10A61K 9/00A61K 47/02A61Q 19/00A61K 38/48A61K 47/36
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Therapeutic composition with a botulinum neurotoxin
- Applicant name
- Merz Pharma GmbH & Co. KGaA
- Opponent name
- ALLERGAN, INC.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c)European Patent Convention Art 76(1)European Patent Convention Art 100(b)European Patent Convention Art 83European Patent Convention Art 100(a)European Patent Convention Art 56
- Keywords
- Divisional application - added subject-matter (no)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.